22-03-29 Polus BioPharm Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
21-11-15 Polus BioPharm Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
19-09-23 Polus BioPharm Inc.(KOSE:A007630) dropped from S&P Global BMI Index CI
19-05-20 POLUS BioPharm Inc. cancelled the acquisition of GTS Korea Co., Ltd. CI
18-12-27 Polus BioPharm Inc. announced that it expects to receive KRW 29.999999966 billion in funding from Polus Holdings Co., Ltd CI
18-09-24 Polus BioPharm Inc.(KOSE:A007630) added to S&P Global BMI Index CI
18-08-27 Polus Inc. announced that it has received KRW 18 billion in funding from POLUS BioPharm Inc. CI
18-08-26 Polus Inc. announced that it expects to receive KRW 18 billion in funding from POLUS BioPharm Inc. CI
18-08-22 Polus BioPharm Inc. announced that it has received KRW 19 billion in funding from Union Savings Bank, Yuil Pe Investment Co.,Ltd., Mason Capital Corporation, Sky Savings Bank, Ltd and other investors CI
18-08-19 POLUS BioPharm Inc. announced that it expects to receive KRW 18 billion in funding from Union Savings Bank, Youil PE Investment, Mason Capital Corporation, Sky Savings Bank, Ltd and another investor CI
18-05-28 POLUS BioPharm Inc. announced that it has received KRW 1.80000415 billion in funding CI
18-05-27 Polus Holdings Co., Ltd acquired additional stake in POLUS BioPharm Inc. from Akaglobal Co. Ltd., G & D Solution Co., Ltd. and PNA Bio Co., Ltd. CI
18-05-24 Polus Inc. announced that it has received KRW 25 billion in funding from Polus BioPharm Inc. CI
Manager TitleAgeSince
Chief Executive Officer 61 2018-01-08
Comptroller/Controller/Auditor 62 2018-01-08
Comptroller/Controller/Auditor 61 2016-07-13
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 61 2018-01-08
Director/Board Member 60 2016-07-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-48.86% - - 1.68M
-8.93%-2.39%+157.25%+433.33% 38.72B
-5.97%-2.45%+105.15%+63.84% 6.42B
+0.13%-0.96%+68.01%+9.69% 3.92B
-9.49%-1.43%+42.42%+76.55% 3.5B
-5.29%+1.59%+67.21%+69.76% 1.54B
-4.32%-0.56%-18.62%+38.82% 1.26B
-5.06%-4.45%+21.52%+218.22% 1.12B
-4.64%+4.35%-11.29%-20.00% 840M
-2.52%+6.32%-4.11%+77.33% 681M
Average -4.61%-5.24%+47.50%+107.51% 6.44B
Weighted average by Cap. -7.62%-9.56%+125.36%+309.16%
Logo Polus BioPharm Inc.
POLUS BioPharm Inc., formerly AMNIS CO., LTD, is a Korea-based company mainly engaged in the manufacture and distribution of communications equipment. The Company operates its business through Communications Equipment Segment, Electronic Measuring Instrument Segment and Other Segment. Its Communications Equipment Segment mainly manufactures repeaters under the brand name of GSI. Its Electronic Measuring Instrument Segment mainly manufactures electronic measuring instruments under the brand name of Protek, and its Other Segment mainly provides communication related services. The Company distributes its products within domestic market and to overseas markets.
Employees
2
  1. Stock Market
  2. Stocks
  3. A007630 Stock